Cargando…
Sarcopenia and Frailty: Challenges in Mainstream Nephrology Practice
Sarcopenia and frailty are prevalent in the chronic kidney disease (CKD) population. Sarcopenia is characterised by the loss of muscle mass and function, while frailty is defined as a multi-system impairment associated with increased vulnerability to stressors. There is substantial overlap between t...
Autores principales: | Wong, Limy, Duque, Gustavo, McMahon, Lawrence P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484128/ https://www.ncbi.nlm.nih.gov/pubmed/34622096 http://dx.doi.org/10.1016/j.ekir.2021.05.039 |
Ejemplares similares
-
The Role of the Kynurenine Pathway in the Pathophysiology of Frailty, Sarcopenia, and Osteoporosis
por: Ballesteros, Juan, et al.
Publicado: (2023) -
Crosstalk between bone and muscle in chronic kidney disease
por: Wong, Limy, et al.
Publicado: (2023) -
COP Cells and Tissue Loss Syndromes: Frailty, Sarcopenia, and Osteoporosis
por: Duque, Gustavo
Publicado: (2021) -
Nephritis and Hearing Loss—Not All Roads Lead to Alport Syndrome
por: Wong, Limy, et al.
Publicado: (2021) -
MiR-423-5p as Optimal Endogenous Control for Quantification of Circulating MicroRNAs in Patients With CKD
por: Wong, Limy, et al.
Publicado: (2023)